Mediator kinase module as a transducer of oncogenic Wnt/β-catenin signaling.

被引：0
|
作者：
Clark, A. D. [1 ]
Oldenbroek, M. [1 ]
Spaeth, J. M. [1 ]
Boyer, T. G. [1 ]
机构：
[1] UT Hlth Sci Ctr San Antonio, Mol Med, San Antonio, TX USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
E79
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Regulation of bone formation by Wnt signaling.
    Patel, MS
    Glass, DA
    Long, F
    Taketo, MM
    McMahon, AP
    Karsenty, G
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 171 - 171
  • [32] Regulation of cartilage matrix turn-over and degradation by Wnt/beta-catenin signaling.
    Yuasa, T.
    Koike, T.
    Hargett, A.
    Pacifici, M.
    Iwamoto, M.
    Enomoto-Iwamoto, M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S79 - S79
  • [33] Targeted Disruption of the BCL9/β-Catenin Complex Inhibits Oncogenic Wnt Signaling
    Takada, Kohichi
    Zhu, Di
    Bird, Gregory H.
    Sukhdeo, Kumar
    Zhao, Jian-Jun
    Mani, Mala
    Lemieux, Madeleine
    Carrasco, Daniel E.
    Ryan, Jeremy
    Horst, David
    Fulciniti, Mariateresa
    Munshi, Nikhil C.
    Xu, Wenqing
    Kung, Andrew L.
    Shivdasani, Ramesh A.
    Walensky, Loren D.
    Carrasco, Daniel Ruben
    SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (148)
  • [34] A Re-evaluation of the "Oncogenic" Nature of Wnt/β-catenin Signaling in Melanoma and Other Cancers
    Lucero, Olivia M.
    Dawson, David W.
    Moon, Randall T.
    Chien, Andy J.
    CURRENT ONCOLOGY REPORTS, 2010, 12 (05) : 314 - 318
  • [35] A Re-evaluation of the “Oncogenic” Nature of Wnt/β-catenin Signaling in Melanoma and Other Cancers
    Olivia M. Lucero
    David W. Dawson
    Randall T. Moon
    Andy J. Chien
    Current Oncology Reports, 2010, 12 : 314 - 318
  • [36] Targeting the interaction of β-catenin and TCF/LEF transcription factors to inhibit oncogenic Wnt signaling
    Koelman, Emma M. R.
    Yeste-Vazquez, Alejandro
    Grossmann, Tom N.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 70
  • [37] SHANK3 in oncogenic RAS signaling.
    Lilja, Johanna
    Jcaquement, Guillaume
    Posada, Itziar Martinez D.
    Laasola, Petra
    Vesilahti, Ella-Maria
    Miihkinen, Mitro
    Salomaa, Siiri
    Kreienkamp, Hans-Juergen
    Barsukov, Igor
    Abankwa, Daniel
    Ivaska, Johanna
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 67 - 67
  • [38] HeyL: A new mammalian mediator of Notch signaling.
    Steidl, C
    Knobeloch, KP
    Leimeister, C
    Maier, M
    Gessler, M
    DEVELOPMENTAL BIOLOGY, 2001, 235 (01) : 252 - 252
  • [39] Treatment of Dkk-1 Inhibits Thyroid Cancer Cell Growth by Regulating Wnt/β-Catenin Signaling.
    Kwak, S. H.
    Cho, S. W.
    Park, Y. J.
    Kim, S. H.
    Ahn, H. Y.
    Kim, M. J.
    Ahn, S. H.
    Kim, S. Y.
    Cho, B. Y.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [40] Notch1 overexpression inhibits osteoblastogenesis by suppressing Wnt/B-catenin but not BMP signaling.
    Deregowski, V
    Gazzerro, E
    Priest, L
    Canalis, E
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S366 - S366
12345